id,patient.id,regime,treatment_date,drug.id,drug.manufacturer,drug.therapy_class
37,201,-,07-Jan-2011,dasabuvir,-,-
38,204,-,05-May-2019,ritonavir,AbbVie,NS5A inhibitor
39,205,-,05-Jun-2019,simeprevir,Janssen,NS3A/4A protease inhibitor
40,205,-,05-Jun-2019,ledipasvir,Gilead,NS5A inhibitor
41,205,-,08-Oct-2020,ritonavir,AbbVie,NS5A inhibitor
42,205,-,07-Feb-2011,paritaprevir,AbbVie,NS3A/4A protease inhibitor
43,226,-,05-Mar-1988,ledipasvir,Gilead,NS5A inhibitor
44,226,-,07-Feb-2011,paritaprevir,AbbVie,NS3A/4A protease inhibitor
45,226,-,05-Jun-2019,ledipasvir,Gilead,NS5A inhibitor
62,207,-,08-Sep-2020,paritaprevir,AbbVie,NS3A/4A protease inhibitor
63,212,1 tablet per day,07-Jan-2011,ombitasvir,AbbVie,NS5B nucleotide polymerase inhibitor
64,218,2 tablets per day,05-Feb-1988,simeprevir,Janssen,NS3A/4A protease inhibitor
